May 06, 2021
1:1000
For every 1000 shares held, investors received 1. The price per share adjusted from $0.01 to $0.00.
The split itself did not change the total investment value.
Immune Therapeutics, Inc. (IMUN) trades on the Other OTC in the Biotechnology industry.
Immune Therapeutics, Inc. company overviewThe latest split shown was on May 6, 2021. It was a 1-for-1000 reverse split, so shareholders received 1 share for every 1000 they held.
This history records 2 reverse splits between February 27, 2012 and May 6, 2021.